- Home
- TMP vs NAGE Comparison
TMP vs NAGE Comparison
Compare TMP & NAGE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TMP
- NAGE
- Stock Information
- Founded
- TMP 1836
- NAGE 1999
- Country
- TMP United States
- NAGE United States
- Employees
- TMP N/A
- NAGE N/A
- Industry
- TMP Major Banks
- NAGE Medicinal Chemicals and Botanical Products
- Sector
- TMP Finance
- NAGE Health Care
- Exchange
- TMP Nasdaq
- NAGE Nasdaq
- Market Cap
- TMP 970.5M
- NAGE 861.0M
- IPO Year
- TMP N/A
- NAGE N/A
- Fundamental
- Price
- TMP $70.14
- NAGE $9.90
- Analyst Decision
- TMP Buy
- NAGE Strong Buy
- Analyst Count
- TMP 2
- NAGE 3
- Target Price
- TMP $69.00
- NAGE $17.00
- AVG Volume (30 Days)
- TMP 40.5K
- NAGE 1.1M
- Earning Date
- TMP 10-24-2025
- NAGE 10-30-2025
- Dividend Yield
- TMP 3.54%
- NAGE N/A
- EPS Growth
- TMP 457.47
- NAGE N/A
- EPS
- TMP 5.55
- NAGE 0.22
- Revenue
- TMP $306,372,000.00
- NAGE $116,303,000.00
- Revenue This Year
- TMP $16.18
- NAGE $28.46
- Revenue Next Year
- TMP $6.47
- NAGE $21.65
- P/E Ratio
- TMP $12.64
- NAGE $46.00
- Revenue Growth
- TMP 39.13
- NAGE 35.90
- 52 Week Low
- TMP $53.95
- NAGE $3.10
- 52 Week High
- TMP $79.01
- NAGE $14.69
- Technical
- Relative Strength Index (RSI)
- TMP 62.90
- NAGE 47.75
- Support Level
- TMP $69.23
- NAGE $9.63
- Resistance Level
- TMP $71.02
- NAGE $10.31
- Average True Range (ATR)
- TMP 1.50
- NAGE 0.41
- MACD
- TMP 0.45
- NAGE 0.08
- Stochastic Oscillator
- TMP 89.51
- NAGE 49.07
About TMP Tompkins Financial Corporation
Tompkins Financial Corp is a Financial Holding Company. It has three business segments, consisting of banking, insurance and wealth management. It offers various products and services, including commercial and consumer banking, leasing, trust and investment management, financial planning and wealth management, and insurance. Insurance is comprised of property and casualty insurance services and employee benefit consulting. Wealth management activities include the results of the company's trust, financial planning, and wealth management services. The company generates majority of its revenue from Banking segment.
About NAGE Niagen Bioscience Inc. Common Stock
Niagen Bioscience Inc is the leader in NAD+ (nicotinamide adenine dinucleotide) science and healthy-aging research. It is dedicated to advancing healthspan through precision science and innovative NAD+-boosting solutions. It is is clinically proven to increase NAD+ levels efficiently and effectively, and is the key ingredient powering our suite of Niagen brands.